Industry
Medical - Devices
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Loading...
Open
11.71
Mkt cap
774M
Volume
103K
High
11.83
P/E Ratio
-7.81
52-wk high
19.10
Low
11.43
Div yield
N/A
52-wk low
2.20
Portfolio Pulse from Vandana Singh
October 30, 2024 | 7:12 pm
Portfolio Pulse from Benzinga Newsdesk
October 24, 2024 | 2:07 pm
Portfolio Pulse from Benzinga Newsdesk
October 24, 2024 | 11:49 am
Portfolio Pulse from Benzinga Newsdesk
October 23, 2024 | 11:11 am
Portfolio Pulse from Benzinga Newsdesk
October 16, 2024 | 11:06 am
Portfolio Pulse from Avi Kapoor
October 11, 2024 | 6:58 pm
Portfolio Pulse from Benzinga Newsdesk
October 11, 2024 | 5:48 pm
Portfolio Pulse from Avi Kapoor
October 11, 2024 | 4:49 pm
Portfolio Pulse from Benzinga Insights
October 11, 2024 | 4:31 pm
Portfolio Pulse from Vandana Singh
October 11, 2024 | 4:05 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.